There were no adverse events due to DNAzyme and there was demonstrable efficacy in both nasopharyngeal cancer and allergic asthma patients.
There were no adverse events due to DNAzyme. There was demonstrable efficacy in both nasopharyngeal cancer. There was demonstrable efficacy in allergic asthma patients.